PAKOLA STEVE sold RGNX

May 11, 2026 · Form 4 insider transaction

PAKOLA STEVE sold 15,309 shares of REGENXBIO Inc. at $11.02 per share, a transaction worth $168.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
15,309
Price
$11.02
Total value
$168.7K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 11, 2026
Filing dateMay 13, 2026
Shares owned after232,617
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan.; This transaction was executed in multiple trades at prices ranging from $11.00 to $11.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR